Chemed Corp (CHE)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Ticker: CHE
Exchange: NYSE
Sector: Healthcare
Industry: Medical Care Facilities
Market cap: $6.87B
52-week range: $365.21 - $562.24

Valuation

Share price: $528.05 (close of Nov 6, 2026)
P/E (TTM): 25.23x
Price to book: 7.98x
Price to free cash flow: 23.26x
Enterprise value: $7.22B
Book value per share: $66.19

Price performance

Period	Change
1 day	-1.07%
5 days	-1.25%
1 month	+3.57%
3 months	-3.89%
6 months	+24.38%
Year to date	+23.42%
1 year	+22.63%
3 years	-9.34%
5 years	+6.39%
10 years	+296.17%
All time	+5,767.22%

Short interest

As of: Oct 15, 2026
Short % of float: 6.24%
Shares short: 685.97K
Days to cover: 4.92
Change since prior report: +14.95%
Source: FINRA consolidated short interest

Profitability and growth

Return on invested capital: 22.05%
Return on capital employed: 27.04%
Gross margin: 32.54%
EBITDA margin: 15.93%
Revenue growth: 4.06%
Free cash flow growth: -11.55%

Cash flow and balance sheet

Free cash flow yield (TTM): 4.30%
Current ratio: 1.11x
Net debt to EBITDA: 0.76x

Latest reported year

Period end: Dec 31, 2025
Fiscal year: 2025
Revenue: $2.53B
Cost of revenue: $1.71B
Gross profit: $823.18M
EBITDA: $403.09M
Earnings per share: $18.42
Interest expense: $1.75M
Shares outstanding: 14.40M

Income statement by year

Period end	Revenue	Gross profit	Net income	EPS
2025-12-31	$2.53B	$823.18M	-	$18.42
2024-12-31	$2.43B	$854.35M	$302.00M	$20.10
2023-12-31	$2.26B	$798.82M	$272.51M	$18.11
2022-12-31	$2.13B	$765.09M	$249.62M	$16.72
2021-12-31	$2.14B	$769.80M	$268.55M	$17.14
2020-12-31	$2.08B	$701.39M	$319.47M	$20.02
2019-12-31	$1.94B	$617.43M	$219.92M	$13.77
2018-12-31	$1.78B	$555.00M	$205.54M	$12.80
2017-12-31	$1.67B	$516.19M	$98.18M	$6.11
2016-12-31	$1.58B	$461.45M	$108.74M	$6.64

Margins and returns by year

Period end	Gross margin	Net margin	Return on equity	Return on capital
2025-12-31	32.54%	-	-	22.05%
2024-12-31	35.14%	12.42%	26.99%	21.35%
2023-12-31	35.28%	12.03%	24.60%	21.06%
2022-12-31	35.84%	11.69%	31.25%	25.19%
2021-12-31	35.98%	12.55%	43.09%	27.60%
2020-12-31	33.73%	15.36%	35.45%	30.21%
2019-12-31	31.85%	11.34%	30.27%	22.88%
2018-12-31	31.13%	11.53%	34.76%	30.80%
2017-12-31	30.97%	5.89%	18.17%	14.70%
2016-12-31	29.26%	6.90%	20.75%	17.45%

Cash and debt by year

Period end	Cash	Debt
2025-12-31	$74.52M	-
2024-12-31	$178.35M	-
2023-12-31	$263.96M	-
2022-12-31	$74.13M	$92.50M
2021-12-31	$32.90M	$185.00M
2020-12-31	$162.68M	-
2019-12-31	$6.16M	$90.00M
2018-12-31	$4.83M	$89.20M
2017-12-31	$11.12M	$91.20M
2016-12-31	$15.31M	$100.00M

Free cash flow by year

Period end	Free cash flow	Stock-based compensation
2025-12-31	$325.48M	$38.68M
2024-12-31	$367.97M	$52.11M
2023-12-31	$273.44M	$40.79M
2022-12-31	$252.56M	$33.61M
2021-12-31	$249.92M	$31.42M
2020-12-31	$430.46M	$26.80M
2019-12-31	$248.23M	$21.34M
2018-12-31	$234.27M	$19.23M
2017-12-31	$98.19M	$16.26M
2016-12-31	$95.62M	$13.77M

Dividend history

Most recent payment: Aug 17, 2026
Paid in the last twelve months: $2.50

Payment date	Dividend per share
2026-08-17	$0.70
2026-05-28	$0.60
2026-02-23	$0.60
2025-11-17	$0.60
2025-08-11	$0.60
2025-05-29	$0.50
2025-02-24	$0.50
2024-11-18	$0.50

Investor relations

Past earnings dates

Reported	Fiscal period	EPS estimate
2026-10-27	Sep 2026	$5.93
2026-07-28	Jun 2026	$5.12
2026-04-23	Mar 2026	$4.85
2026-02-25	Dec 2025	$6.57
2025-10-28	Sep 2025	$4.94
2025-07-29	Jun 2025	$4.27
2025-04-23	Mar 2025	$5.19
2025-02-26	Dec 2024	$6.34

Filings and sources

Company website: chemed.com
SEC filings: 10-K, 10-Q and 8-K on EDGAR
Earnings calendar: All upcoming reports

Similar companies

HCA Healthcare, Inc. (HCA) · DaVita Inc. (DVA) · Universal Health Services Inc (UHS) · Thermo Fisher Scientific Inc. (TMO) · Danaher Corp (DHR) · Natera, Inc. (NTRA) · Agilent Technologies, Inc. (A) · IQVIA Holdings Inc. (IQV)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades